• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Early salvage radiation therapy of the prostate bed appears to be equally effective compared to adjuvant radiation therapy after radical prostatectomy].

作者信息

Shelan M, Aebersold D, Ghadjar P

机构信息

Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Schweiz.

Klinik für Radioonkologie und Strahlentherapie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany, Augustenburger Platz 1, 13353, Berlin, Deutschland.

出版信息

Strahlenther Onkol. 2020 Apr;196(4):406-409. doi: 10.1007/s00066-020-01591-2.

DOI:10.1007/s00066-020-01591-2
PMID:32060583
Abstract
摘要

相似文献

1
[Early salvage radiation therapy of the prostate bed appears to be equally effective compared to adjuvant radiation therapy after radical prostatectomy].与根治性前列腺切除术后辅助性放疗相比，前列腺床早期挽救性放疗似乎同样有效。
Strahlenther Onkol. 2020 Apr;196(4):406-409. doi: 10.1007/s00066-020-01591-2.
2
Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.前列腺癌根治性前列腺切除术后辅助放疗和挽救性放疗的治疗结果。
Int J Clin Oncol. 2007 Feb;12(1):37-41. doi: 10.1007/s10147-006-0622-1. Epub 2007 Feb 25.
3
Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up.前列腺癌根治术后前列腺特异性抗原水平升高患者的延迟/挽救性放射治疗。长期随访。
Cancer. 1996 Sep 15;78(6):1254-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1254::AID-CNCR13>3.0.CO;2-#.
4
Adjuvant and salvage radiotherapy after radical prostatectomy.前列腺癌根治术后的辅助放疗和挽救性放疗。
Onkologie. 2002 Jun;25(3):201-6. doi: 10.1159/000064312.
5
Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?前列腺癌根治术后复发高危患者的术后放射治疗：时机重要吗？
BJU Int. 2015 Nov;116(5):713-20. doi: 10.1111/bju.13043. Epub 2015 May 26.
6
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.根治性前列腺切除术（GETUG-AFU 16）后 PSA 浓度升高时的挽救性放疗联合或不联合短期激素治疗：一项随机、多中心、开放性 3 期临床试验。
Lancet Oncol. 2016 Jun;17(6):747-756. doi: 10.1016/S1470-2045(16)00111-X. Epub 2016 May 6.
7
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.在接受根治性前列腺切除术治疗的pN1前列腺癌患者中，与挽救性放射治疗相比，辅助性放射治疗与更好的肿瘤学结果相关。
BJU Int. 2017 May;119(5):717-723. doi: 10.1111/bju.13679. Epub 2016 Nov 21.
8
A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.多机构分析比较前列腺切除术后 PSA 检测不到的高危前列腺癌患者的辅助和挽救性放疗。
Radiother Oncol. 2010 Dec;97(3):474-9. doi: 10.1016/j.radonc.2010.07.008. Epub 2010 Oct 13.
9
Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy.根治性前列腺切除术后挽救性放疗的疗效和耐受性，重点关注适合辅助放疗的高危患者。
Radiother Oncol. 2010 Dec;97(3):467-73. doi: 10.1016/j.radonc.2010.05.023.
10
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.雄激素剥夺治疗联合挽救性放疗用于前列腺癌根治术后生化复发患者。
Strahlenther Onkol. 2018 Jul;194(7):619-626. doi: 10.1007/s00066-018-1269-3. Epub 2018 Jan 30.

本文引用的文献

1
Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection.辅助放疗对淋巴结阳性前列腺癌患者的影响：患者选择的重要性。
Eur Urol. 2018 Sep;74(3):253-256. doi: 10.1016/j.eururo.2018.04.017. Epub 2018 Apr 30.
2
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.辅助性与早期挽救性前列腺癌根治术后放疗治疗伴有不良病理特征前列腺癌的比较。
JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230.
3
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
前列腺癌根治术后辅助和挽救性放疗。
Eur Urol. 2017 Nov;72(5):689-709. doi: 10.1016/j.eururo.2017.01.039. Epub 2017 Feb 8.
4
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.开发和验证一种 24 基因预测因子，用于预测前列腺癌术后放疗的反应：一项匹配、回顾性分析。
Lancet Oncol. 2016 Nov;17(11):1612-1620. doi: 10.1016/S1470-2045(16)30491-0. Epub 2016 Oct 12.
5
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.前列腺切除术后放疗对经临床和基因组风险调整的队列的疗效。
Prostate Cancer Prostatic Dis. 2016 Sep;19(3):277-82. doi: 10.1038/pcan.2016.15. Epub 2016 May 3.
6
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.基因组分类器可识别接受根治性前列腺切除术的男性中具有不良病理的患者，这些患者从辅助放疗中获益。
J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9.
7
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.根治性前列腺切除术后前列腺特异性抗原持续存在是临床无复发生存和总生存的预测因素：ARO 96-02 试验的 10 年数据。
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):288-94. doi: 10.1016/j.ijrobp.2014.09.039. Epub 2014 Nov 20.
8
Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis.pT3 期前列腺癌辅助放疗与观察等待的 3 期研究：病理复查对分析的影响。
Eur Urol. 2013 Aug;64(2):193-8. doi: 10.1016/j.eururo.2013.03.029. Epub 2013 Mar 17.
9
Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.选择前列腺癌根治性前列腺切除术后辅助放疗的最佳候选者：长期生存分析。
Eur Urol. 2013 Jun;63(6):998-1008. doi: 10.1016/j.eururo.2012.10.036. Epub 2012 Oct 26.
10
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.辅助性激素和放疗联合治疗显著延长了 pT2-4 pN+前列腺癌患者的生存时间：一项匹配分析的结果。
Eur Urol. 2011 May;59(5):832-40. doi: 10.1016/j.eururo.2011.02.024. Epub 2011 Feb 22.